:.START

Oncor Inc, Gaithersburg, Md say U.S. Food and Drug Administration don approve am to market agric test wey go help for diagnosis, and treatment of leukemia and lymph cancer.

Di B/T gene rearrangement test na im accurate pass for di assessment of di type of cancer weda e spread or e dey follow treatment, Oncor President Stephen Turner.

Oga Turner talk sey first na im go do di test na im go do am with biopsies, and oder tests na im go later be di benchmark for tomorrow analysis.

Oga Turner talk sey di test go take 45 days go inside hospital, and clinical laboratory.

Dr. Wyndham Wilson wey be cancer specialist for National Cancer Institute, talk sey dem dey too use research centre dey do am, but no be sey e dey important because e dey only useful to choose the most effective treatment.

But di test may be more sensitive in determining wheder a tumoro don spread, or return following treatment, Dr. Wilson say, we never know yet how useful it is going to be, e say.

Oncor, one six years old developer of agric medical test, project wey be sey cancer test go help am take get di first ever profit during di first quarter of 1990, Oga Turner talk.

Di company go charge $35 for one test, and project about $2 million in revenue from di test during di first 12 months of marketing.

